Spectrum Pharmaceuticals SPPI
$ 1.03
0.0%
Quarterly report 2023-Q1
added 05-11-2023
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Joseph Turgeon |
Employees in the company |
146 |
Shares |
183 M |
Market Cap[1] |
$ 189 M |
EBITDA (LTM) |
$ -77.2 M |
P/E (LTM) |
-2.67 |
P/S (LTM) |
2.42 |
EPS (LTM) |
-0.49 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.